Deep learning classification of deep ultraviolet fluorescence images toward intra-operative margin assessment in breast cancer
Frontiers in Oncology · 16.06.2023 · 13
DOI: 10.3389/fonc.2023.1179025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 16.06.2023. Verfasst von Tyrell To und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Electrical and Computer Engineering, Marquette University, Opus College of Engineering, Milwaukee, WI, United States. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIBIB NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Background
Breast-conserving surgery is aimed at removing all cancerous cells while minimizing the loss of healthy tissue. To ensure a balance between complete resection of cancer and preservation of healthy tissue, it is necessary to assess themargins of the removed specimen during the operation. Deep ultraviolet (DUV) fluorescence scanning microscopy provides rapid whole-surface imaging (WSI) of resected tissues with significant contrast between malignant and normal/benign tissue. Intra-operative margin assessment with DUV images would benefit from an automated breast cancer classification method.
Methods
Deep learning has shown promising results in breast cancer classification, but the limited DUV image dataset presents the challenge of overfitting to train a robust network. To overcome this challenge, the DUV-WSI images are split into small patches, and features are extracted using a pre-trained convolutional neural network—afterward, a gradient-boosting tree trains on these features for patch-level classification. An ensemble learning approach merges patch-level classification results and regional importance to determine the margin status. An explainable artificial intelligence method calculates the regional importance values.
Results
The proposed method’s ability to determine the DUV WSI was high with 95% accuracy. The 100% sensitivity shows that the method can detect malignant cases efficiently. The method could also accurately localize areas that contain malignant or normal/benign tissue.
Conclusion
The proposed method outperforms the standard deep learning classification methods on the DUV breast surgical samples. The results suggest that it can be used to improve classification performance and identify cancerous regions more effectively.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Electrical and Computer Engineering, Marquette University, Opus College of Engineering, Milwaukee, WI, United States.
- Joint Department of Biomedical Engineering, Marquette University and Medical College of Wisconsin, Milwaukee, WI, United States.
- Department of Pathology, Medical College of Wisconsin, Milwaukee, WI, United States.
- Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, United States.
- Department of Computer Science, Georgia State University, Atlanta, GA, United States.
Förderung
- NIBIB NIH HHS
- National Institutes of Health
Zitieren
APA
To, T., Lu, T., Jorns, J. M., Patton, M., Schmidt, T. G., Yen, T., Yu, B., & Ye, D. H. (2023). Deep learning classification of deep ultraviolet fluorescence images toward intra-operative margin assessment in breast cancer. Frontiers in Oncology, 13. https://doi.org/10.3389/fonc.2023.1179025
Vancouver
To T, Lu T, Jorns JM, Patton M, Schmidt TG, Yen T, et al. Deep learning classification of deep ultraviolet fluorescence images toward intra-operative margin assessment in breast cancer. Frontiers in Oncology. 2023;13. doi:10.3389/fonc.2023.1179025
BibTeX
@article{To2023,
author = {To, Tyrell and Lu, Tongtong and Jorns, Julie M and Patton, Mollie and Schmidt, Taly Gilat and Yen, Tina and Yu, Bing and Ye, Dong Hye},
title = {Deep learning classification of deep ultraviolet fluorescence images toward intra-operative margin assessment in breast cancer},
journal = {Frontiers in Oncology},
year = {2023},
volume = {13},
doi = {10.3389/fonc.2023.1179025}
}
EUVIMED